a developer of allogeneic chimeric antigen receptor therapy
Industry Biotechnology
A.I.dvisor indicates that over the last year, ALLO has been loosely correlated with FATE. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ALLO jumps, then FATE could also see price increases.
Ticker / NAME | Correlation To ALLO | 1D Price Change % | ||
---|---|---|---|---|
ALLO | 100% | -7.72% | ||
FATE - ALLO | 58% Loosely correlated | -2.88% | ||
NTLA - ALLO | 56% Loosely correlated | -7.61% | ||
BEAM - ALLO | 55% Loosely correlated | -8.59% | ||
CRSP - ALLO | 54% Loosely correlated | +0.85% | ||
CRBU - ALLO | 54% Loosely correlated | -4.78% | ||
More |